Main Article Content

Александр Викторович Мурзин
Оксана Александровна Мелкозерова
Гузель Нуховна Чистякова
Анастасия Александровна Гришкина

Abstract

The effect of gestational diabetes mellitus (GSD) on the mother and fetus is determined by an increased risk of obstetric and perinatal complications. Pregnancy resulting from assisted reproductive technologies (ART) may also carry obstetric risks associated with the effect of hormonal stimulation on implantation processes and the formation of the uteroplacental complex. The pathogenetic mechanisms of the development of these pregnancy complications are associated with placental dysfunction, which manifests itself at different gestation periods and affects the development of complications.
Purpose of the study – to study the pathomorphological features of placentas in patients with gestational diabetes mellitus, whose pregnancy occurred because of assisted reproductive technologies.
Material and methods. A pathomorphological study of 86 placentas in women after ART was performed. The patients were divided into 2 study groups. Group I (main group) consisted of patients with GSD after ART (n = 45), group II (comparison group) – patients after ART without GSD (n = 41). The first group, depending on the presence or absence of perinatal complications of pregnancy, was divided into two subgroups: 1 – patients with perinatal complications (n = 29), 2 – patients without perinatal complications (n = 32). Depending on the type of ART programs, subgroups were identified: 3 patients who underwent an embryo transfer program (PE) in a cryoprotocol (n = 58) and 4 patients who underwent PE in a superovulation stimulation cycle (n = 29). All patients underwent a clinical and anamnestic assessment of pregnancy and childbirth, as well as a morphological examination of the placentas after delivery.
Results. The patients of the study groups were comparable in age and anthropometric parameters (p > 0.05). The presence of a burdened obstetric and gynecological history (medical abortion, spontaneous miscarriage, non-developing pregnancy, p = 0.001) and extragenital diseases (pathology of the cardiovascular system (OR 3.84; 1.23–11.96; p = 0.003), hypothyroidism (OR 5.53; 1.42-21.29; p = 0.008), pathology of the urinary system (OR 4.96; 1.47-16.92; p = 0.007) was statistically significantly more often observed in patients of the main group. Morphological assessment of placentas in women after ART with GDM verified a significantly larger mass of placentas (p = 0.042), damage to the microstructure of the placenta in the form of vascular thrombosis (p = 0.033), signs of maternal malperfusion (p = 0.011).In patients after ART with the development of perinatal complications against the background of GDM, distal villous immaturity (p = 0.021), excessive fibrinoid deposition in the intervillous space (p = 0.047), compensatory formation of syncytial nodes (p = 0.034), a high incidence of maternal malperfusion (p = 0.011) and chronic basal deciduitis (p = 0.029). Microscopic examination of placentas in patients with PE in the superovulation stimulation cycle revealed a significantly higher frequency of fibrinoid deposition in the intervillous space (p = 0.044) with compensatory formation of syncytiotrophoblastic nodes (p = 0.044) compared to the cryotransfer group, and delayed villous maturation (p = 0.010), which was realized in the form of maternal and fetal malperfusion (p = 0.023), thrombosis of vessels in the intervillous space (p = 0.041), and was also accompanied by inflammatory changes in the decidual tissue (p = 0.029).
Conclusion. There is a certain synergy regarding the effect of GDM and the use of ART methods on the morphofunctional state of the feto-placental complex, which may further increase the risks of obstetric and perinatal complications in this category of patients.

Keywords

gestational diabetes mellitus, assisted reproductive technologies, pregnancy complications, maternal vascular malperfusion, placental pathology

Author Biographies

Александр Викторович Мурзин,
graduate student, researcher of the department antenatal fetus protection
Оксана Александровна Мелкозерова,
doctor of medical sciences, docent, deputy director for science
Гузель Нуховна Чистякова,
doctor of medical sciences, professor, honored scientist, head of the scientific department of microbiology, immunology, pathomorphology and cytodiagnostics
Анастасия Александровна Гришкина,
candidate of medical sciences, senior researcher, acting head of the laboratory of pathomorphology and cytodiagnostics

Article Details

Information about financing and conflict of interests

The study had no sponsorship.
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.

How to Cite

Мурзин, А. В., Мелкозерова, О. А., Чистякова, Г. Н., & Гришкина, А. А. (2024). THE INFLUENCE OF GESTATIONAL DIABETES MELLITUS ON THE MORPHOFUNCTIONAL STATE OF PLACENTAS IN PATIENTS AFTER THE USE OF ASSISTED REPRODUCTIVE TECHNOLOGIES. Mother and Baby in Kuzbass, 25(2), 20-29. https://doi.org/10.24412/2686-7338-2024-2-20-29

References

Dalfrà M.G., Burlina S., Del Vescovo G.G., et al. Genetics and epigenetics: new insight on gestational diabetes mellitus. Journal of Frontiers in Endocrinology. 2020; 11: 602477.

https://doi.org/10.3389/fendo.2020.602477

Billionnet C., Mitanchez D., Weill A., Nizard J., Alla F., Hartemann A., Jacqueminet S. Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012. Journal of Diabetologia. 2017; 60(4): 636-644.

https://doi.org/10.1007/s00125-017-4206-6

Gao R., Zhao K., Zhou J., Wang X., Liu T., Lian S., Li J., Huang Y., Qiu C., Wu Y., He J., Liu C. Effects of gestational diabetes mellitus and assisted reproductive technology treatment on the risk of preterm singleton birth. Journal of Frontiers in Nutrition. 2022; 14(9): 977195.

https://doi.org/10.3389/fnut.2022.977195

Bianchi C., Brocchi A., Baronti W., Nicolì F., Citro F., Aragona M., Cela V., Del Prato S., Bertolotto A. Assisted reproductive technology, risk of gestational diabetes, and perinatal outcomes in singleton pregnancies. Journal of Diabetes metabolism research and reviews. 2023; 39(5): e3625.

https://doi.org/10.1002/dmrr.3625

Bosdou J.K, Anagnostis P., Goulis D.G, Lainas G.T., Tarlatzis B.C, Grimbizis G.F, Kolibianakis E.M. Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis. Human Reproduction Update.2020; 26(4):514-544.

https://doi.org/10.1093/humupd/dmaa011

Çelik A.O., Günay B., Çoker G.B., Ustabaşıoğlu F.E., Ateş S., Tunçbilek N. Evaluation of placenta in patients with gestational diabetes using shear wave elastography and superb microvascular imaging. Journal of Acta radiologica. 2023; 18: 2841851231217201.

https://doi.org/10.1177/02841851231217201

Li YX, Long DL, Liu J, Qiu D, Wang J, Cheng X, Yang X, Li RM, Wang G. Gestational diabetes mellitus in women increased the risk of neonatal infection via inflammation and autophagy in the placenta. Medicine (Baltimore). 2020 Oct 2;99(40):e22152. https://doi.org/10.1097/MD.0000000000022152

Haavaldsen C., Tanbo T., Eskild A. Placental weight in singleton pregnancies with and without assisted reproductive technology: A population study of 536,567 pregnancies. Journal of Human Reproduction. 2012; 27: 576–582. https://doi.org/10.1093/humrep/der428

Kovo M., Granot Y., Schreiber L., Divon M., Ben-Haroush A., Bar J. Pregnancy outcome and placental pathology differences in term gestational diabetes with and without hypertensive disorders. The journal of maternal-fetal and neonatal medicine. 2016; 29(9): 1462-1467

Zhao Y.J., Zhang H.J., Li C.X., Wu T., Shen X.M., Zhang J. Selecting placental measures that have clinical implications in child development and diseases. Journal of Placenta. 2014; 35(3): 178-87.

https://doi.org/10.1016/j.placenta.2014.01.006

Huynh J., Yamada J., Beauharnais C., Wenger J.B., Thadhani R.I., Wexler D., Roberts D.J., Bentley-Lewis R. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Journal of Placenta. 2015; 36(10): 1161-1166. https://doi.org/10.1016/j.placenta.2015.08.004

Akarsu S., Bagirzade M., Omeroglu S., Büke B. Placental vascularization and apoptosis in Type-1 and gestational DM. The journal of maternal-fetal and neonatal medicine. 2017; 30(9): 1045-1050.

https://doi.org/10.1080/14767058.2016.1199676

Meng Q, Shao L, Luo X, Mu Y, Xu W, Gao C, Gao L, Liu J, Cui Y. Ultrastructure of placenta of gravidas with gestational diabetes mellitus. Obstetrics and gynecology international. 2015; 2015: 283124.

https://doi.org/10.1155/2015/283124

Goto T., Sato Y., Kodama Y., Tomimori K., Sameshima H., Aman M., Maekawa K., Yamashita A., Asada Y. Association between fetal vascular malperfusion and gestational diabetes. The journal of obstetrics and gynaecology research. 2022; 48(1): 80-86.

https://doi.org/10.1111/jog.15046

Ashfaq M., Janjua M.Z., Channa M.A. Effect of gestational diabetes and maternal hypertension on gross morphology of placenta. Journal of Ayub Medical College, Abbottabad. 2005; 17(1): 44–47. PMID: 15929527

Saha S., Biswas S., Mitra D., Adhikari A., Saha C. Histologic and morphometric study of human placenta in gestational diabetes mellitus. Italian journal of anatomy and embryology. 2014; 119(1): 1-9. PMID: 25345070

Memon G.P., Lata H. Gross and histological alteration in the placenta of mothers suffering from gestational diabetes. Journal of Liaquat University of Medical and Health Sciences. 2015; 14(1): 16-20

Carrasco-Wong I, Moller A, Giachini FR, Lima VV, Toledo F, Stojanova J, Sobrevia L, San Martín S. Placental structure in gestational diabetes mellitus. Biochimica et biophysica acta. Molecular basis of disease. 2020; 1866(2): 165535.

https://doi.org/10.1016/j.bbadis.2019.165535

Catov J.M., Peng Y., Scifres C.M., Parks W.T. Placental pathology measures: can they be rapidly and reliably integrated into large-scale perinatal studies? Journal of Placenta. 2015; 36(6): 687-92.

https://doi.org/10.1016/j.placenta.2015.03.001

Edu A., Teodorescu C., Dobjanschi C.G., Socol Z.Z., Teodorescu V., Matei A., Albu D.F., Radulian G. Placenta changes in pregnancy with gestational diabetes. Romanian journal of morphology and embryology. 2016; 57(2): 507-512. PMID: 27516026

T Vilariño-García T, Pérez-Pérez A, Dietrich V, Fernández-Sánchez M, Guadix P, Dueñas JL, Varone CL, Damiano AE, Sánchez-Margalet V. Increased expression of aquaporin 9 in trophoblast from gestational diabetic patients. Hormone and metabolic research. 2016; 48(8): 535-539.

https://doi.org/10.1055/s-0042-105152

Hung T.H., Huang S.Y., Chen S.F., Wu C.P., Hsieh T.T. Decreased placental apoptosis and autophagy in pregnancies complicated by gestational diabetes with large-for-gestational age fetuses. Journal of Placenta. 2020; 90: 27-36.

https://doi.org/10.1016/j.placenta.2019.12.003

Downloads

Download data is not yet available.

Most read articles by the same author(s)

1 2 > >>